Connection

Karel Kostev to Dipeptides

This is a "connection" page, showing publications Karel Kostev has written about Dipeptides.
Connection Strength

0.687
  1. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
    View in: PubMed
    Score: 0.687
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.